These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17401522)

  • 21. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
    Paviour DC; Price SL; Stevens JM; Lees AJ; Fox NC
    Neurology; 2005 Feb; 64(4):675-9. PubMed ID: 15728291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphometry MRI in the differential diagnosis of parkinsonian syndromes.
    Gama RL; Távora DF; Bomfim RC; Silva CE; Bruin VM; Bruin PF
    Arq Neuropsiquiatr; 2010 Jun; 68(3):333-8. PubMed ID: 20602031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
    Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
    J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Worker A; Blain C; Jarosz J; Chaudhuri KR; Barker GJ; Williams SC; Brown R; Leigh PN; Simmons A
    PLoS One; 2014; 9(12):e114167. PubMed ID: 25463618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
    Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF
    Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "One line": A method for differential diagnosis of parkinsonian syndromes.
    Sako W; Abe T; Haji S; Murakami N; Osaki Y; Izumi Y; Harada M; Kaji R
    Acta Neurol Scand; 2019 Sep; 140(3):229-235. PubMed ID: 31225648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
    Tsai RM; Lobach I; Bang J; Whitwell JL; Senjem ML; Jack CR; Rosen H; Miller B; Boxer AL;
    Parkinsonism Relat Disord; 2016 Jul; 28():29-35. PubMed ID: 27132501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.
    Massey LA; Micallef C; Paviour DC; O'Sullivan SS; Ling H; Williams DR; Kallis C; Holton JL; Revesz T; Burn DJ; Yousry T; Lees AJ; Fox NC; Jäger HR
    Mov Disord; 2012 Dec; 27(14):1754-62. PubMed ID: 22488922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI.
    Blain CR; Barker GJ; Jarosz JM; Coyle NA; Landau S; Brown RG; Chaudhuri KR; Simmons A; Jones DK; Williams SC; Leigh PN
    Neurology; 2006 Dec; 67(12):2199-205. PubMed ID: 17190944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.
    Whitwell JL; Xu J; Mandrekar JN; Gunter JL; Jack CR; Josephs KA
    Parkinsonism Relat Disord; 2012 Mar; 18(3):252-6. PubMed ID: 22079523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
    Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential of a new MRI for visualizing cerebellar involvement in progressive supranuclear palsy.
    Hara K; Watanabe H; Ito M; Tsuboi T; Watanabe H; Nakamura R; Senda J; Atsuta N; Adachi H; Aiba I; Naganawa S; Sobue G
    Parkinsonism Relat Disord; 2014 Feb; 20(2):157-61. PubMed ID: 24172606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
    Albrecht F; Bisenius S; Neumann J; Whitwell J; Schroeter ML
    Neuroimage Clin; 2019; 22():101722. PubMed ID: 30831462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.
    Gilman S; Koeppe RA; Nan B; Wang CN; Wang X; Junck L; Chervin RD; Consens F; Bhaumik A
    Neurology; 2010 May; 74(18):1416-23. PubMed ID: 20439843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.
    Huppertz HJ; Möller L; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Respondek G; Stamelou M; Schnitzler A; Pinkhardt EH; Oertel WH; Knake S; Kassubek J; Höglinger GU
    Mov Disord; 2016 Oct; 31(10):1506-1517. PubMed ID: 27452874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.